Studies on the effect of methotrexate on macrophage function.

Area of Science:

• Immunology
• Pharmacology
• Rheumatology

Background:

• Adjuvant arthritis in rats is a model for human inflammatory diseases.
• Resident peritoneal macrophages play a key role in arthritis pathogenesis through cytokine production and antigen presentation.
• Interleukin-1 (IL-1) and Ia antigen expression on macrophages are critical inflammatory mediators.

Purpose of the Study:

• To investigate the effect of low-dose methotrexate on IL-1 synthesis and Ia antigen expression in rat adjuvant arthritis.
• To determine if methotrexate's effects are direct or indirect on macrophages.

Main Methods:

• Time course studies in adjuvant-immunized rats.
• Analysis of IL-1 synthesis by resident peritoneal macrophages.
• Assessment of Ia antigen expression on macrophages.
• In vitro experiments with methotrexate and lipopolysaccharide (LPS).

Main Results:

• Macrophage IL-1 synthesis peaked at days 10-11 post-immunization.
• Ia antigen expression increased significantly between days 15-20 and remained high.
• Methotrexate treatment decreased IL-1 synthesis and Ia expression.
• In vitro, methotrexate did not inhibit LPS-induced IL-1 synthesis.

Conclusions:

• Low-dose methotrexate modulates macrophage function in adjuvant arthritis.
• Methotrexate's therapeutic effect may involve reducing IL-1 production and Ia expression in vivo.
• The drug's action appears to be indirect, not a direct inhibition of macrophage activation by LPS.